anmelden
Novo Nordisk Aktie
41,51
EUR
+0,01
EUR
+0,02
%
41,48
EUR
-0,11
EUR
-0,25
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.03.19 | Novo Nordisk Reduce | HSBC | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.02.19 | Novo Nordisk Reduce | HSBC | |
| 05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
| 04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 04.02.19 | Novo Nordisk Neutral | Credit Suisse Group | |
| 01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
| 02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.12.18 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 11.12.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 29.11.18 | Novo Nordisk neutral | Kepler Cheuvreux | |
| 26.11.18 | Novo Nordisk Reduce | HSBC | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.18 | Novo Nordisk Reduce | HSBC | |
| 05.11.18 | Novo Nordisk buy | UBS AG | |
| 02.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.18 | Novo Nordisk Hold | CFRA | |
| 02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 02.11.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 01.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.10.18 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 12.10.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 12.10.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 10.10.18 | Novo Nordisk buy | UBS AG | |
| 10.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.10.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 05.10.18 | Novo Nordisk buy | UBS AG | |
| 04.10.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 04.10.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.09.18 | Novo Nordisk Reduce | HSBC | |
| 19.09.18 | Novo Nordisk Reduce | HSBC | |
Werbung
Werbung